Literature DB >> 18317953

Silent familial isolated pituitary adenomas: histopathological and clinical case report.

C Villa1, F Magri, P Morbini, A Falchetti, P Scagnelli, E Lovati, D Locatelli, F R Canevari, V Necchi, E Gabellieri, G Guabello, L Chiovato, E Solcia.   

Abstract

Familial isolated pituitary adenoma (FIPA) is a rare condition independent of Carney Complex or MEN1. An international multicenter study recently described 28 nonfunctioning pituitary adenomas in 26 families with only two homogeneous nonsecreting phenotype families consistent of silent GH and silent gonadotroph adenomas, respectively. We present the clinical, genetic, and morphological analysis of two silent pituitary adenomas occurring in a man and his daughter, and discuss the differential diagnosis associated with their histological, immunohistochemical, and ultrastructural features. The patients developed invasive nonsecreting macroadenomas manifesting only with compressive symptoms. Genetic analysis in the father showed no MEN-1 germ-line mutation. Tissue samples obtained after paraseptal trans-sphenoidal surgery were studied by immunohistochemistry for adenohypophyseal hormones, low molecular weight cytokeratins (CAM 5.2), proliferation markers, and anterior pituitary transcription factors (Pit-1 and SF-1) and by electron microscopy for secretory granules. The clinical, histological, and immunohistochemical features of the lesions posed a differential diagnosis between a null cell adenoma and a silent corticotroph adenoma (Type II); on the basis of immunohistochemical stains for cytokeratin and adenohypophysis cell lineage markers, tumor behavior and ultrastructural studies we concluded for the second. The reported cases represent an as yet undescribed example of homogeneous family with silent corticotroph adenomas (Type II). Our observations support the trend for more aggressive behavior in nonsecreting FIPAs as compared with sporadic adenomas.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18317953     DOI: 10.1007/s12022-008-9018-2

Source DB:  PubMed          Journal:  Endocr Pathol        ISSN: 1046-3976            Impact factor:   3.943


  36 in total

1.  Double adenomas of the pituitary: transcription factors Pit-1, T-pit, and SF-1 identify cytogenesis and differentiation.

Authors:  R A Jastania; K O Alsaad; M Al-Shraim; K Kovacs; S L Asa
Journal:  Endocr Pathol       Date:  2005       Impact factor: 3.943

2.  Clinical characterization of familial isolated pituitary adenomas.

Authors:  A F Daly; M-L Jaffrain-Rea; A Ciccarelli; H Valdes-Socin; V Rohmer; G Tamburrano; C Borson-Chazot; B Estour; E Ciccarelli; T Brue; P Ferolla; P Emy; A Colao; E De Menis; P Lecomte; F Penfornis; B Delemer; J Bertherat; J L Wémeau; W De Herder; F Archambeaud; A Stevenaert; A Calender; A Murat; F Cavagnini; A Beckers
Journal:  J Clin Endocrinol Metab       Date:  2006-06-20       Impact factor: 5.958

3.  MEN1 family with a novel frameshift mutation.

Authors:  V Nuzzo; L Tauchmanová; A Falchetti; A Faggiano; F Marini; S Piantadosi; M L Brandi; L Leopaldi; A Colao
Journal:  J Endocrinol Invest       Date:  2006-05       Impact factor: 4.256

4.  Thymic neuroendocrine carcinoma (carcinoid) in multiple endocrine neoplasia type 1 syndrome: the Italian series.

Authors:  P Ferolla; A Falchetti; P Filosso; P Tomassetti; G Tamburrano; N Avenia; G Daddi; F Puma; R Ribacchi; F Santeusanio; G Angeletti; M L Brandi
Journal:  J Clin Endocrinol Metab       Date:  2005-02-15       Impact factor: 5.958

5.  Familial prolactinoma.

Authors:  L G Sobrinho
Journal:  Clin Endocrinol (Oxf)       Date:  1995-10       Impact factor: 3.478

Review 6.  Familial acromegaly: case report and review of the literature.

Authors:  A Verloes; A Stevenaert; B T Teh; P Petrossians; A Beckers
Journal:  Pituitary       Date:  1999-05       Impact factor: 4.107

7.  Absence of germ-line mutations of the multiple endocrine neoplasia type 1 (MEN1) gene in familial pituitary adenoma in contrast to MEN1 in Japanese.

Authors:  C Tanaka; K Yoshimoto; S Yamada; H Nishioka; S Ii; M Moritani; T Yamaoka; M Itakura
Journal:  J Clin Endocrinol Metab       Date:  1998-03       Impact factor: 5.958

8.  Postoperative surveillance of clinically nonfunctioning pituitary macroadenomas: markers of tumour quiescence and regrowth.

Authors:  Y Greenman; G Ouaknine; I Veshchev; I I Reider-Groswasser; Y Segev; N Stern
Journal:  Clin Endocrinol (Oxf)       Date:  2003-06       Impact factor: 3.478

9.  Familial acromegaly: a specific clinical entity--further evidence from the genetic study of a three-generation family.

Authors:  P Benlian; S Giraud; N Lahlou; M Roger; C Blin; C Holler; G Lenoir; J Sallandre; A Calender; G Turpin
Journal:  Eur J Endocrinol       Date:  1995-10       Impact factor: 6.664

10.  Gigantism in sibling unrelated to multiple endocrine neoplasia: case report.

Authors:  A Matsuno; A Teramoto; S Yamada; S Kitanaka; T Tanaka; N Sanno; R Y Osamura; T Kirino
Journal:  Neurosurgery       Date:  1994-11       Impact factor: 4.654

View more
  2 in total

1.  Prevalence of double pituitary adenomas in a surgical series: Clinical, histological and genetic features.

Authors:  F Magri; C Villa; D Locatelli; P Scagnelli; M S Lagonigro; P Morbini; M Castellano; E Gabellieri; M Rotondi; E Solcia; A F Daly; L Chiovato
Journal:  J Endocrinol Invest       Date:  2009-12-01       Impact factor: 4.256

Review 2.  Familial isolated pituitary adenomas (FIPA) and the pituitary adenoma predisposition due to mutations in the aryl hydrocarbon receptor interacting protein (AIP) gene.

Authors:  Albert Beckers; Lauri A Aaltonen; Adrian F Daly; Auli Karhu
Journal:  Endocr Rev       Date:  2013-01-31       Impact factor: 19.871

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.